Figure 2.
Two-way sensitivity analyses, showing ICER for NBS of SCID as a function of treatment cost per late-identified SCID who receive HCT as first-line therapy and cumulative survival in late-identified SCID.
Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.